242 related articles for article (PubMed ID: 31605809)
1. The emergence of rare nocardiosis following allogeneic hematopoietic stem cell transplantation in the era of molecular taxonomy.
Kurosawa S; Sekiya N; Doki N; Yaguchi T; Kishida Y; Nagata A; Yamada Y; Konishi T; Kaito S; Yoshifuji K; Shirane S; Uchida T; Inamoto K; Toya T; Igarashi A; Najima Y; Muto H; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Int J Infect Dis; 2019 Dec; 89():154-162. PubMed ID: 31605809
[TBL] [Abstract][Full Text] [Related]
2. Nocardiosis at the turn of the century.
Minero MV; Marín M; Cercenado E; Rabadán PM; Bouza E; Muñoz P
Medicine (Baltimore); 2009 Jul; 88(4):250-261. PubMed ID: 19593231
[TBL] [Abstract][Full Text] [Related]
3. Disseminated nocardiosis after unrelated bone marrow transplantation.
Hino Y; Doki N; Senoo Y; Sekiya N; Kurosawa S; Tsuboi S; Ohashi K
Transpl Infect Dis; 2016 Dec; 18(6):942-945. PubMed ID: 27696601
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors and Outcomes of Nocardiosis in Hematopoietic Stem Cell Transplantation Recipients.
Yetmar ZA; Thoendel MJ; Bosch W; Seville MT; Hogan WJ; Beam E
Transplant Cell Ther; 2023 Mar; 29(3):206.e1-206.e7. PubMed ID: 36526261
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain.
Valdezate S; Garrido N; Carrasco G; Medina-Pascual MJ; Villalón P; Navarro AM; Saéz-Nieto JA
J Antimicrob Chemother; 2017 Mar; 72(3):754-761. PubMed ID: 27999029
[TBL] [Abstract][Full Text] [Related]
6. Nocardiosis following hematopoietic stem cell transplantation.
Shannon K; Pasikhova Y; Ibekweh Q; Ludlow S; Baluch A
Transpl Infect Dis; 2016 Apr; 18(2):169-75. PubMed ID: 26809666
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility profiles of Nocardia isolates based on current taxonomy.
Schlaberg R; Fisher MA; Hanson KE
Antimicrob Agents Chemother; 2014; 58(2):795-800. PubMed ID: 24247124
[TBL] [Abstract][Full Text] [Related]
8. Clinical features, identification, antimicrobial resistance patterns of Nocardia species in China: 2009-2017.
Huang L; Chen X; Xu H; Sun L; Li C; Guo W; Xiang L; Luo G; Cui Y; Lu B
Diagn Microbiol Infect Dis; 2019 Jun; 94(2):165-172. PubMed ID: 30679058
[TBL] [Abstract][Full Text] [Related]
9. Clinical manifestations and outcome of nocardiosis and antimicrobial susceptibility of Nocardia species in southern Taiwan, 2011-2021.
Yang CH; Kuo SF; Chen FJ; Lee CH
J Microbiol Immunol Infect; 2023 Apr; 56(2):382-391. PubMed ID: 36456442
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic susceptibility testing and species identification of Nocardia isolates: a retrospective analysis of data from a French expert laboratory, 2010-2015.
Lebeaux D; Bergeron E; Berthet J; Djadi-Prat J; Mouniée D; Boiron P; Lortholary O; Rodriguez-Nava V
Clin Microbiol Infect; 2019 Apr; 25(4):489-495. PubMed ID: 29933049
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility profiles and species distribution of medically relevant Nocardia species: Results from a large tertiary laboratory in Australia.
Tan YE; Chen SC; Halliday CL
J Glob Antimicrob Resist; 2020 Mar; 20():110-117. PubMed ID: 31400449
[TBL] [Abstract][Full Text] [Related]
12. Rare case of osteomyelitis of tibial shaft caused by Nocardia cyriacigeorgica.
Raszka D; Popelka S; Heřt J; Jahoda D; Landor I; Vavřík P
Folia Microbiol (Praha); 2018 Jul; 63(4):525-532. PubMed ID: 29508232
[TBL] [Abstract][Full Text] [Related]
13. Genetic diversity and antimicrobial susceptibility of Nocardia species among patients with nocardiosis.
Hashemi-Shahraki A; Heidarieh P; Bostanabad SZ; Hashemzadeh M; Feizabadi MM; Schraufnagel D; Mirsaeidi M
Sci Rep; 2015 Dec; 5():17862. PubMed ID: 26638771
[TBL] [Abstract][Full Text] [Related]
14. MLSA phylogeny and antimicrobial susceptibility of clinical Nocardia isolates: a multicenter retrospective study in China.
Wei M; Xu X; Yang J; Wang P; Liu Y; Wang S; Yang C; Gu L
BMC Microbiol; 2021 Dec; 21(1):342. PubMed ID: 34903163
[TBL] [Abstract][Full Text] [Related]
15. [Microbiological and clinical features of nine cases with nocardial infections].
Maki Y; Uchida Y; Monji N; Mochimaru T; Morokuma Y; Karashima T; Kiyosuke M; Fujise M; Eto F; Miyake N; Shimono N; Kayamori Y; Kang D
Rinsho Byori; 2011 Mar; 59(3):213-8. PubMed ID: 21560401
[TBL] [Abstract][Full Text] [Related]
16. Clinical and microbiological characteristics of infections caused by various Nocardia species in Taiwan: a multicenter study from 1998 to 2010.
Liu WL; Lai CC; Ko WC; Chen YH; Tang HJ; Huang YL; Huang YT; Hsueh PR
Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1341-7. PubMed ID: 21461846
[TBL] [Abstract][Full Text] [Related]
17. Clinical manifestations and antimicrobial susceptibility of Nocardia species at a tertiary hospital in Taiwan, 2011-2020.
Lao CK; Tseng MC; Chiu CH; Chen NY; Chen CH; Chung WH; Liu TP; Lu JJ; Lai HC; Yang LY; Lee CH; Wu TS
J Formos Med Assoc; 2022 Oct; 121(10):2109-2122. PubMed ID: 35811270
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the duration of trimethoprim/sulfamethoxazole treatment and the clinical outcome of pulmonary nocardiosis.
Tashiro H; Takahashi K; Kusaba K; Tanaka M; Komiya K; Nakamura T; Aoki Y; Kimura S; Sueoka-Aragane N
Respir Investig; 2018 Mar; 56(2):166-172. PubMed ID: 29548655
[TBL] [Abstract][Full Text] [Related]
19. Nocardiosis in 132 patients with cancer: microbiological and clinical analyses.
Wang HL; Seo YH; LaSala PR; Tarrand JJ; Han XY
Am J Clin Pathol; 2014 Oct; 142(4):513-23. PubMed ID: 25239419
[TBL] [Abstract][Full Text] [Related]
20. Isolation and Characterization of Nocardia Species from Pulmonary Nocardiosis in a Tertiary Hospital in China.
Li J; Shen H; Yu T; Tao XY; Hu YM; Wang HC; Zou MX
Jpn J Infect Dis; 2022 Jan; 75(1):31-35. PubMed ID: 34053953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
